Hepatitis A vaccine response in HIV-infected patients: Are TWINRIX® and HAVRIX® interchangeable?

Highlights ► We assessed the impact of factors on Hepatitis A vaccine response in HIV patients. ► Seroconversion occurred in 54% of the HIV-infected patients receiving Hep A vaccine. ► Responders had higher CD4 counts and lower viral loads than non-responders. ► Viral suppression and vaccine series...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 31; no. 9; pp. 1328 - 1333
Main Authors Jimenez, Humberto R, Hallit, Rabih R, DeBari, Vincent A, Slim, Jihad
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 18.02.2013
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights ► We assessed the impact of factors on Hepatitis A vaccine response in HIV patients. ► Seroconversion occurred in 54% of the HIV-infected patients receiving Hep A vaccine. ► Responders had higher CD4 counts and lower viral loads than non-responders. ► Viral suppression and vaccine series completion impacted TWINRIX® more than HAVRIX® . ► HAVRIX® and TWINRIX® may not be interchangeable in HIV-infected patients.
Bibliography:http://dx.doi.org/10.1016/j.vaccine.2012.12.045
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.12.045